Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
Current SymbolNYSE:CHE
Previous Symbol
CUSIP16359R10
Phone513-762-6690
Debt
Debt-to-Equity Ratio0.23
Current Ratio1.14
Quick Ratio1.11
Price-To-Earnings
Trailing P/E Ratio57.55
Forward P/E Ratio27.04
P/E Growth2.66
Sales & Book Value
Annual Sales$1.67 billion
Price / Sales2.96
Cash Flow$8.1173 per share
Price / Cash Flow38.01
Book Value$33.84 per share
Price / Book9.12
Profitability
EPS (Most Recent Fiscal Year)$5.36
Net Income$98.17 million
Net Margins11.73%
Return on Equity35.13%
Return on Assets20.40%
Miscellaneous
Employees14,813
Outstanding Shares16,010,000
Market Cap$4.85 billion
OptionableOptionable
Chemed (NYSE:CHE) Frequently Asked Questions
What is Chemed's stock symbol?
Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed pay dividends? What is the dividend yield for Chemed?
Chemed announced a quarterly dividend on Friday, November 2nd. Shareholders of record on Monday, November 12th will be paid a dividend of $0.30 per share on Monday, December 3rd. This represents a $1.20 annualized dividend and a yield of 0.39%. The ex-dividend date is Thursday, November 8th. View Chemed's Dividend History.
How will Chemed's stock buyback program work?
Chemed announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, March 7th 2018, which permits the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued.
How were Chemed's earnings last quarter?
Chemed Co. (NYSE:CHE) released its earnings results on Monday, October, 29th. The company reported $3.07 earnings per share for the quarter, beating the consensus estimate of $2.80 by $0.27. The firm earned $444.15 million during the quarter, compared to analyst estimates of $445.16 million. Chemed had a return on equity of 35.13% and a net margin of 11.73%. Chemed's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.15 earnings per share. View Chemed's Earnings History.
When is Chemed's next earnings date?
What guidance has Chemed issued on next quarter's earnings?
Chemed issued an update on its FY18 earnings guidance on Monday, October, 29th. The company provided earnings per share guidance of $11.80-11.90 for the period, compared to the Thomson Reuters consensus estimate of $11.47. Chemed also updated its FY 2018 guidance to $11.80-11.90 EPS.
What price target have analysts set for CHE?
3 analysts have issued 1 year target prices for Chemed's shares. Their forecasts range from $275.00 to $390.00. On average, they anticipate Chemed's stock price to reach $328.6667 in the next year. This suggests a possible upside of 6.9% from the stock's current price. View Analyst Price Targets for Chemed.
What is the consensus analysts' recommendation for Chemed?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.
Has Chemed been receiving favorable news coverage?
News headlines about CHE stock have been trending positive this week, InfoTrie reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemed earned a daily sentiment score of 2.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days.
Who are some of Chemed's key competitors?
Who are Chemed's key executives?
Chemed's management team includes the folowing people:
- Mr. Kevin J. McNamara, CEO, Pres & Director (Age 64)
- Mr. David P. Williams, Exec. VP & CFO (Age 57)
- Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 64)
- Mr. Spencer S. Lee, Exec. VP (Age 62)
- Mr. Nicholas Michael Westfall, Exec. VP (Age 39)
Who are Chemed's major shareholders?
Chemed's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.63%), BlackRock Inc. (10.48%), Neuberger Berman Group LLC (4.32%), Acadian Asset Management LLC (3.58%), Riverbridge Partners LLC (3.04%) and Fisher Asset Management LLC (2.95%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.
Which institutional investors are selling Chemed stock?
CHE stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, JPMorgan Chase & Co., JPMorgan Chase & Co., Gamco Investors INC. ET AL, Paloma Partners Management Co, Hsbc Holdings PLC, Deutsche Bank AG and Gabelli Funds LLC. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.
Which institutional investors are buying Chemed stock?
CHE stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, First Trust Advisors LP, Allianz Asset Management GmbH, Canada Pension Plan Investment Board, Rehmann Capital Advisory Group, Schroder Investment Management Group, Capital Fund Management S.A. and Janus Henderson Group PLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.
How do I buy shares of Chemed?
Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemed's stock price today?
One share of CHE stock can currently be purchased for approximately $307.33.
How big of a company is Chemed?
Chemed has a market capitalization of $4.85 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe.
What is Chemed's official website?
How can I contact Chemed?
Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.
MarketBeat Community Rating for Chemed (NYSE CHE)
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
